Prognostic benefit of preoperative transarterial chemoembolization in upfront resectable large hepatocellular carcinoma: a multicentric propensity score based analysis of European high-volume centers.
Fiche publication
Date publication
mars 2024
Journal
HPB : the official journal of the International Hepato Pancreato Biliary Association
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PESSAUX Patrick
Tous les auteurs :
Giannone F, Felli E, Cipriani F, Branciforte B, Rhaiem R, Al Taweel B, Brustia R, Salame E, Panaro F, Sommacale D, Piardi T, Torzilli G, Aldrighetti L, Schuster C, Pessaux P
Lien Pubmed
Résumé
Hepatocellular carcinoma (HCC) have a dismal prognosis and any effective neoadjuvant treatment has been validated to date. We aimed to investigate the role of neoadjuvant transarterial chemoembolization (TACE) in upfront resectable HCC larger than 5 cm.
Référence
HPB (Oxford). 2024 03 20;: